AH
Anat Hakim (EVP, GC & Secretary) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Eli Lilly and Company (LLY). The largest single filing was $7.0M of LLY (5,000 sh × $1,402.52, as filed), executed Nov 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$13.0M
shares × price, as filed
Last traded
Nov 2
Filed Nov 3
Median ADV $3.8B across their filed names
Open performance→Volume by month
Buys $0
Sells $13.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
LLYRecent filings
LLYSALE
Eli Lilly and Company
View filing →
$7.0M5,000 sh × $1,402.52
Exec Nov 2
Filed Nov 3 · 4:14 PM ET LLYSALE Eli Lilly and Company View filing → $6.0M
5,000 sh × $1,190.00
Exec Aug 7
Filed Aug 10 · 4:19 PM ET